GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » EV-to-Revenue

Hyphens Pharma International (SGX:1J5) EV-to-Revenue : 0.45 (As of Jun. 01, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hyphens Pharma International's enterprise value is S$88.2 Mil. Hyphens Pharma International's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was S$195.4 Mil. Therefore, Hyphens Pharma International's EV-to-Revenue for today is 0.45.

The historical rank and industry rank for Hyphens Pharma International's EV-to-Revenue or its related term are showing as below:

SGX:1J5' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.23   Med: 0.45   Max: 1.24
Current: 0.45

During the past 10 years, the highest EV-to-Revenue of Hyphens Pharma International was 1.24. The lowest was 0.23. And the median was 0.45.

SGX:1J5's EV-to-Revenue is ranked better than
86.1% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 1.81 vs SGX:1J5: 0.45

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), Hyphens Pharma International's stock price is S$0.305. Hyphens Pharma International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was S$0.62. Therefore, Hyphens Pharma International's PS Ratio for today is 0.49.


Hyphens Pharma International EV-to-Revenue Historical Data

The historical data trend for Hyphens Pharma International's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International EV-to-Revenue Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.65 0.46 0.44 0.42

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 - 0.44 - 0.42

Competitive Comparison of Hyphens Pharma International's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's EV-to-Revenue falls into.


;
;

Hyphens Pharma International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hyphens Pharma International's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=88.199/195.42
=0.45

Hyphens Pharma International's current Enterprise Value is S$88.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hyphens Pharma International's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was S$195.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hyphens Pharma International's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.305/0.621
=0.49

Hyphens Pharma International's share price for today is S$0.305.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was S$0.62.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment; and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International Headlines

No Headlines